12 results
P
patients with rare disease, caregivers
I/C
health-related quality of life (HRQOL), other chronic disease groups, general population in Hong Kong
O
lower HRQOL
P
South Africa, India, Turkey, Pakistan, Canada, Hong Kong, China
I/C
α-HCH, β-HCH, γ-HCH, ∑-HCH, Heptachlor, Aldrin, p,p'-DDE, p,p'-DDT, ∑-DDT, ∑-OCP, Surface water, Drinking water, Seawater, Groundwater
O
Concentration and prevalence of POPs, Carcinogenic risk, Non-carcinogenic risk
P
Chinese children under 18 years old
I/C
urban vs. rural areas, Northern China vs. Southern China, Hong Kong, Macau and Taiwan vs. mainland China
O
prevalence of refractive error (myopia, high myopia, hyperopia, astigmatism)
P
female patients with primary dysmenorrhea
I/C
sham acupuncture, no intervention or other treatments
O
pain intensity, retrospective symptom scale, health-related quality of life
P
patients with musculoskeletal pain
I/C
marine-derived resources, seawater, mineral water, ocean therapy, no intervention
O
osteoarthritis severity, arthritis pain, fibromyalgia pain, quality of life
P
OL, PVL, AC
I/C
treatment, recurrence, MT
O
4.53 higher chance of recurrence, 6.52 higher chance of MT
P
youth
I/C
treatments, existing treatments
O
behavior problems, callous-unemotional traits
P
uHCC, HAIC, sorafenib
I/C
HAIC-based treatments, triple therapy, AIPB
O
effective treatment
P
celiac disease (CD)
I/C
skin cancer, controls
O
non-melanoma skin cancers (NMSC)
P
patients with schizophrenia, healthy control subjects
I/C
assessment of sexual functioning, schizophrenia vs. healthy control
O
risk of sexual dysfunction